Clinical Trial Update: The Ward Study for SeptiCyte® Lab to Distinguish Between Infection-positive and Infection-negative SIRS

View source ↗

Summary

The Ward Study evaluating SeptiCyte Lab to distinguish infection-positive from infection-negative SIRS has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Systemic Inflammatory Response Syndrome

Drugs mentioned

• SeptiCyte Lab

Snippet

Sponsor: Immunexpress | Conditions: Sepsis, SIRS | Status: TERMINATED